Articles

PRMA Consulting becomes Avalere Health, creating the connections that make better health happen

World Orphan Drug Congress 2023: solutions for market access and HEOR

Welcoming Lewis Ruff, Senior Director, Global HEOR, within our policy, access, value, and evidence capability

Adapting to Change: Strategies for Pharma Service Providers, CROs, and R&D Partnerships in the Era of the Inflation Reduction Act

Welcoming Tyler Piazza, Partnerships Director, HEOR and hēRo3, within our policy, access, value, and evidence capability

Welcoming Caroline Solon, Senior Director Global Market Access, within our policy, access, value, and evidence capability

The hēRo3 Revolution: Accelerating and Empowering HEOR Analytics with Cutting-Edge Digital Solutions

Digital therapeutics: value, evidence, and access in the Asia-Pacific region

Driving BioPharma value, evidence, and access in Romania

Evidence supporting reimbursement of digital therapeutics

European Joint Clinical Assessments: are you ready?

Driving BioPharma value, evidence, and access in the Netherlands

Reducing the care gap in cancer prevention, diagnosis, and treatment

Digital therapeutics: pathways for reimbursement across international markets

Evidence generation and launch strategies in China

The rise of precision medicine

Digital therapeutics: what are the challenges for reimbursement?

Driving BioPharma value, evidence, and access in Finland

ISPOR 2023: insight from Avalere’s expert presentations

Why a market access career in Singapore is so rewarding

My role as a Senior Director in market access

AMCP 2023: key trends and highlights

Driving BioPharma value, evidence, and access in the Czech Republic

E-learning for market access professionals

Driving BioPharma value, evidence, and access in Bulgaria

Showcasing Robust Policy, Access, Value, and Evidence Solutions at ISPOR 2023, Boston, May 7–10

Principles of HTA Early Scientific Advice for market access

5 benefits of e-learning for your market access teams

Market access careers in the Asia-Pacific region: it’s a great time to join our team 

The benefits of utilizing Early Scientific Advice within market access

Cell and gene therapies: common challenges for market access

Avalere’s Healthcare Industry Outlook Report 2023

5 ways we’re enhancing our services to support our biopharmaceutical, medical technology, and wellness clients in 2023

The lasting impact of the Inflation Reduction Act: a Q&A with Jon Koch, CEO, Fishawack Health

Cell and gene therapies: what are they and how many are in development?

How our mobile working philosophy was inspired by our colleagues

Asia-Pacific life sciences market access and financing: key trends

Why it’s time to apply a payer lens to your early pipeline planning

Why market access and evidence-generation needs to amplify the patient voice 

Diversity, equity, and inclusion: a year in review

Market access and evidence generation: the evolving uses of real-world data

Why a career in market access is the right choice for me

ASH Annual Meeting 2022

The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia

2023 Avalere Healthcare Industry Outlook Webinar: Gain Clarity 

Moving from “Wealth = Health” to “Health = Wealth”: building value-based healthcare financing models that deliver equitable access in Asia-Pacific

Practical advice for Early Scientific Advice in health technology assessment submissions

The last mile to healthcare: reimagining strategic supply chains in the Asia-Pacific region to ensure equitable supply across and within markets

Optimize your market access strategies for diagnostics and devices

The fast-paced future of cell and gene therapies

Learning from the Lionesses to achieve your workplace goals

Emphasizing the patient voice in health technology assessments

Transgender Visibility: the importance of workplace inclusivity and allyship

Impact of The Use of Cost-Effectiveness Analysis (CEA) on Patient Access to Medicines: A Comparison of CEA vs. Non-CEA Markets

Women and football: An ongoing journey

Securing trust in the healthcare system: how does this help drive access and equity in the Asia-Pacific region?

What manufacturers should know about companion diagnostics access pathways in the Asia-Pacific region

Integrated Evidence Generation 2.0: a strategy for every stakeholder

Health in your pocket: leveraging digital solutions to empower community-centered and patient-centric care models in Asia-Pacific

The future of market access: a new model for the ‘next normal’

Deepavali, India’s Festival of Lights (aka Diwali)

International Pronoun Day: The importance of using gender pronouns in our workplaces 

Life as Head of Client Partnerships (US) at PRMA Consulting, a member of Fishawack Health

Partnering for health in Asia-Pacific: building strategic partnerships to achieve goals for access and equity

Reinventing product and portfolio value for the biopharmaceutical industry

ISPOR Europe 2022: from pipeline assets to patient access

Achieving equitable access to healthcare innovation in the complex Southeast Asian Nations region

Macmillan coffee morning at PRMA Consulting, a member of Fishawack Health.

Black History Month 2022: Our Diversity, Equity, and Inclusion team share what Black History Month means to them

How a new technology add-on payment (NTAP) works

Maximizing the value of your asset by leveraging real-world evidence 

Medicare negotiation could reduce manufacturer revenues by US$165 billion 

What is Real-world evidence?

National Healthcare Security Administration (NHSA) of China announces drug list up for National Reimbursement negotiation

Several changes to adult vaccine access enacted through the IRA 

How real-world evidence supports market access for high cost/low volume therapies 

PRMA Consulting as Knowledge Partner in Zuellig Pharma’s 2nd Healthcare Access Summit – “Building a Healthier Asia: Empowering more equitable access to healthcare innovation” 

Real-world evidence: the importance of effective collaboration with healthcare professionals 

The importance of LGBTQ+ role models at work

The patient voice – the value of patient-reported outcomes in HTA 

A unique opportunity to learn, collaborate, and create solutions: my experience as a market access intern at PRMA Consulting

World Alzheimer’s Month: know dementia, know Alzheimer’s

US pre-approval information exchange: building a pre-approval information exchange strategy in 3 steps

What US market access professionals need to know about pre-approval information exchange

Early preparedness before your US market access and HEOR teams are established: 5  key considerations 

New malnutrition reporting measure, developed by Avalere Health and the Academy of Nutrition and Dietetics, is now available for reporting 

Principles and benefits of HTA early scientific advice

Enjoying the journey as a market access intern at PRMA Consulting

5 ways to smartly manage your market access information using digital applications

“Stronger Together, Majulah!” – A celebration of the National Day of Singapore

Playing for the team and enjoying the journey are two company values that resonate with me

Why earlier value assessment of your assets through a payer lens makes a difference for market access

Right sizing your approach to market access to influence how value is captured and demonstrated in early clinical development

Surviving versus thriving as a woman working in tech

CMS announces the Enhancing Oncology Model as the successor to the Oncology Care Model

Digital health technologies: 5 challenges for market access and reimbursement

Why client delivery excellence is built on a foundation of team development

Fishawack Health adds leading US healthcare policy experts Avalere

Fishawack Health is proud to announce that Avalere joins its team

What is a global value dossier?

Pride month 2022: why we recognize pride in our workplaces

Supporting mental health awareness in our international workplaces

Key Trends in Asia-Pacific

Critical factors to successful US payer negotiations

Adjusting to the increasing focus on value-based pricing

Eid Mubarak

Policy, Access, Value, and Evidence: 4 key trends for 2022

Skysis and PRMA Consulting look forward to connecting with you at Asembia 2022

Omnichannel recommendations for the life science industry

Try this omnichannel maturity tool to gain an instant analysis of your omnichannel readiness

Vaisakhi: my celebration of joy and connection

Ramadan Kareem

Καλό Πάσχα, Kalo Pascha, Happy Orthodox Easter!

Neurodiversity in the workplace: the importance of neurodivergent business leaders as role models

International Women’s Day: Deborah Keller, Chairperson of Fishawack Health, on gender, resilience, and yoga

Are your market access digital applications delivering maximum value? 5 KPIs every digital product leader needs to know

Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)

The insights that are strengthening connections amongst new members of the PRMA Consulting team

Recognizing the International Day for the Elimination of Racial Discrimination in our workplaces

Employee wellbeing scores 93% at PRMA Consulting and bucks workplace trends

Gong hei fatt choy and gong xi fa cai: wishing you great happiness and prosperity this Chinese New Year

Something for everybody? A holistic approach to market access in emerging markets

How Paul Abi-Aad is strengthening value, evidence, and access collaboration in his new role as Client Partnership Lead

Team Member Achievement Awards 2021

Demonstrate the value of vaccines: 7 updates examining NITAG and HTA requirements

The role of NITAGs and HTA agencies in decision-making for vaccines

Welcoming FIDE, a leading network of dermatology experts, to the Fishawack Health group

Recognizing Disability History Month in the workplace: 4 ways you can raise awareness at work

Federal drug price regulations: is ‘Build Back Better’ a direction-altering precedent leveraging copycat actions?

Women in technology: a career in an organization that values diversity

Fishawack Gives Back: supporting healthcare causes through our new philanthropic program

Vaccine appraisals in France: who are the key stakeholders?

How pricing models for vaccines vary between countries

Evaluation of vaccines: guidance on evidence and modeling requirements

New experts strengthen client partnerships in PRMA Consulting’s Asia-Pacific market access team

Sheena Amin-Liebman joins Fishawack Health in the newly created role of Diversity & Inclusion Director

Empowering people of color in clinical trials: a reflection on Martin Luther King Jr. Day

How my market access internship opportunity helped me develop my individual skillset

10 inspiring Black healthcare pioneers

Black History Month: celebrating 10 pioneers in healthcare

Addressing inequities in access to healthcare: 4 recommendations for biopharma manufacturers

Using economic models and cost-utility analyses to explore the cost-effectiveness of vaccines

Economic evaluation of vaccines: why is a QALY a recommended measure of benefit?

Supporting the Fleet Phoenix charity in the Manchester Half Marathon

Liz Landon joins Fishawack Health to deliver a first-class experience for colleagues

ICER and Value Assessment Frameworks: 5 key insights for biopharma

5 insights for improving pharmaceutical market access in Asia-Pacific

US healthcare review: pandemic, politics, pricing, and the payer landscape

The team that eats together, advances together

Fishawack Health welcomes new CEO Jonathan Koch

How an assessment of NITAG and HTA evidence requirements can help manufacturers establish the value of their vaccine

Menopause and work: initiatives to support employees

LGBTQ+ History Month in the workplace

5 lessons in healthcare innovation from pioneers in care and treatment

Preparing for market access success in a crowded landscape: learnings from a plaque psoriasis case study

PM Society Digital Awards finalist announced: the PRMA Navigator®

Why a market access internship is a fantastic way to kick-start your career

Writing a great GVD that balances a clear global value story with local payer requirements

10 considerations for conducting health economic evaluations of vaccines

Vaccine reimbursement: helping you prepare for success

The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor

Gender pronouns: why using gender-inclusive language at work matters at PRMA Consulting

The untold stories of healthcare innovation: a new podcast

Diversity and inclusion in the workplace

Showcasing the women who are pioneering market access technology

Gaining the most benefit from your market access digital applications

Market access for regenerative medicines and rare disease therapies

D&I update: the first of our international diversity and inclusion training sessions

Information is pharma’s new competitive advantage – make sure you protect it

The digitalization of healthcare: are you ready?

Welcoming our Senior Director and Head of Market Access & HEOR in Asia-Pacific

Fishawack Health expands its global market access and HEOR capabilities with the acquisition of PRMA Consulting

Navigating the US payer landscape and the evolving influence of ICER

PRMA Consulting named one of Pharma Tech Outlook’s top consulting companies

Beating work-related stress

Go-to market access consultancy welcomes Bharath Rao as Digital Product Owner

Tips for dealing with the stress of working from home

A day in the life of a pharmaceutical market access consultant

10 ways to help manage stress when working from home

Helping you get the most market access value from your digital applications

Five ways to break down the silos that stall digital transformation

Market access strategies and services for Asia-Pacific

Take your market access to the next level: your free digital transformation eBook

Employee satisfaction survey: the importance of colleague engagement at PRMA Consulting

The importance of core values for wellbeing at work

Why wellbeing at work is no longer a company perk

Why culture is king in employers of choice

A career development framework for market access consultancy

Well-being initiatives that work

Take your market access to the next level: your free digital transformation eBook

3 reasons to pursue a career in market access consultancy

Digital technology is transforming market access, but insight has a human heartbeat

Driving market access readiness in the US through a unique digital application

Cornerstones of ‘fair’ drug coverage: ICER and OHE release new white paper

PM Society Digital Awards: market access award winner

CMS releases its annual IPPS final rule: key updates for manufacturers

PRMA Consulting announces its new office opening in Singapore

How will Covid-19 shape the evidence assessed by payers and HTA decision-makers?

Why understanding payer archetypes is key to US market access

Digital transformation in market access: don’t get lost in translation

Completing the puzzle: market access in Asia-Pacific

Preparing for ICER assessments: key recommendations for manufacturers

Why on-demand insight is key to successful payer submissions

ICER 2020 value assessment framework: 7 updates that market access professionals need to understand

Digital transformation: shaping the future of market access

How collaboration and connectivity can accelerate payer submissions and drive faster patient access

Breaking boundaries in market access: PRMA Consulting annual company meeting 2020

WEConnect: Connecting Women’s Enterprises with Global Opportunities

Payer and HTA submissions: how digital technology is transforming market access processes

Reducing market access risk: how digital technology is strengthening strategies

Home working: 6 tips for fostering team connectivity in times of distance and disruption

COVID-19: how your market access can fly even when you are grounded

Wellbeing at PRMA Consulting

PRMA Consulting expands its US presence

Driving market access success in the US

How a leading pharma company gained significant market access insights prior to launch

How to drive payer submission readiness for your late-phase products

Digitization in primary research: a smart addition to traditional market access research methods

The things you need to know about the digital transformation of primary research

Are you in touch with the latest payer thinking?

Transforming value and access outcomes in the Asia-Pacific region

The influence of the patient voice in regulatory and health technology assessment activities

How to identify the potential for commercial success in early-stage product development

Managed entry agreements: learnings for successful development from a UK perspective

Managed entry agreements: theory and principals

Payer insight: 5 ways to get the most from your advisor interactions

Finalist in the HealthEconomics.com’s 1st Annual HEOR and RWE Innovation Webinar Series: the PRMA Navigator^®

The Fierce Innovation Award identifying outstanding innovation in Life Sciences

Digital innovation empowers global teams and local affiliates to shorten the time to market access

Mapping patient involvement in NICE appraisals of oncology products

Watch and vote in the 2019 Health Economics Innovation Series

Orphan drug re-assessments in Germany: the impact on additional benefit and price

Do your global value dossiers contain these 5 common omissions?

How digital technology is transforming market access in the Asia-Pacific region

Free eBook: how to accelerate the generation of simultaneous, high-quality HTA submissions

Overcoming the market access challenges associated with high-cost combination therapies

Pricing and reimbursement in Canada: a market access update

Potential solutions for pricing and reimbursement of high-cost combination products

The relevance of patient perspectives to value

Incorporating the patient voice in market access

Pricing and reimbursement of CAR‐T in Germany

Managed entry agreements: regional and national insight

Measuring survival benefit in oncology health technology assessments

Exploring the benefits of cloud computing for market access.

Protecting your market access data. 10 questions to ask your suppliers

Protect your market access data: the value of ISO27001

Four recommendations to kick-start the digital transformation of your market access processes

Exploring the challenges for pricing and reimbursement of high-cost combination therapies

Managed entry agreements: regional and national insight in market access

Five strategies for CAR-T pricing and reimbursement success

Review of CAR-T assessments and implications for novel agents

Recommendations for successfully developing managed entry agreements

Designing effective managed entry agreements: insight from Spain

Patient-centricity: a crucial approach for market access?

Biosimilars: market access considerations

Exploring the challenges for pricing and reimbursement of high-cost combination therapies

Transforming the market access landscape: the role of digital applications

Evaluate how digital technology can better enable processes and requirements

PRMA Consulting Expert Advisory Group on Complex Pricing (EAGCP): Focus on gene therapies

Achieving a variable price by indication: free eBook download

Indication-based pricing: your free eBook download